ID

34431

Description

Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT02486354

Lien

https://clinicaltrials.gov/show/NCT02486354

Mots-clés

  1. 17/01/2019 17/01/2019 -
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

17 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Non-small Cell Lung Cancer NCT02486354

Eligibility Non-small Cell Lung Cancer NCT02486354

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed locally advanced/metastatic (stage iiib/stage iv, using the american joint committee on cancer [ajcc] 6th edition of tumor-node-metastasis [tnm] staging system) nsclc patients
Description

ID.1

Type de données

boolean

progressed after at least one platinum-based chemotherapy regimen at entry
Description

ID.2

Type de données

boolean

eastern cooperative oncology group (ecog) performance status (ps) 0-2
Description

ID.3

Type de données

boolean

at least one measurable lesion by response evaluation criteria in solid tumors version 1.0
Description

ID.4

Type de données

boolean

adequate hematologic and biochemical values
Description

ID.5

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with symptomatic brain metastases
Description

ID.6

Type de données

boolean

malignant tumor within the previous five years
Description

ID.7

Type de données

boolean

severe infection; congestive heart failure
Description

ID.8

Type de données

boolean

previous treatment with drugs targeting egfr
Description

ID.9

Type de données

boolean

history of interstitial lung disease
Description

ID.10

Type de données

boolean

Similar models

Eligibility Non-small Cell Lung Cancer NCT02486354

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
histologically or cytologically confirmed locally advanced/metastatic (stage iiib/stage iv, using the american joint committee on cancer [ajcc] 6th edition of tumor-node-metastasis [tnm] staging system) nsclc patients
boolean
ID.2
Item
progressed after at least one platinum-based chemotherapy regimen at entry
boolean
ID.3
Item
eastern cooperative oncology group (ecog) performance status (ps) 0-2
boolean
ID.4
Item
at least one measurable lesion by response evaluation criteria in solid tumors version 1.0
boolean
ID.5
Item
adequate hematologic and biochemical values
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
patients with symptomatic brain metastases
boolean
ID.7
Item
malignant tumor within the previous five years
boolean
ID.8
Item
severe infection; congestive heart failure
boolean
ID.9
Item
previous treatment with drugs targeting egfr
boolean
ID.10
Item
history of interstitial lung disease
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial